Skip to main content
Top

Clinical & Experimental Metastasis

Issue 2/2003

Content (10 Articles)

Anti-tumor immunoglobulin M increases lung metastasis in an experimental model of malignant melanoma

Nu-man Tsai, Bing-Mae Chen, Shao-Lun Wei, Cheng-Wen Wu, Steve R. Roffler

GFP-transfected tumor cells are useful in examining early metastasis in vivo, but immune reaction precludes long-term tumor development studies in immunocompetent mice

Markus Steinbauer, Markus Guba, Grigore Cernaianu, Gudrun Köhl, Michaela Cetto, Leoni A. Kunz-Schughart, Edward K. Geissler, Werner Falk, Karl-Walter Jauch

Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cells

Rachael C. Casey, Theodore R. Oegema Jr., Keith M. Skubitz, Stefan E. Pambuccian, Suzanne M. Grindle, Amy P.N. Skubitz

A novel bisphosphonate minodronate (YM529) specifically inhibits osteolytic bone metastasis produced by human small-cell lung cancer cells in NK-cell depleted SCID mice

Helong Zhang, Seiji Yano, Toyokazu Miki, Hisatsugu Goto, Takanori Kanematsu, Hiroaki Muguruma, Hisanori Uehara, Saburo Sone

EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma

Ben Davidson, Iris Goldberg, Aasmund Berner, Gunnar B. Kristensen, Reuven Reich

Real-time GFP imaging of spontaneous HT-1080 fibrosarcoma lung metastases

Norio Yamamoto, Meng Yang, Ping Jiang, Hiroyuki Tsuchiya, Katsuro Tomita, A.R. Moossa, Robert M. Hoffman

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine